Skip to main content
BRIGHT MINDS BIOSCIENCES INC. logo

BRIGHT MINDS BIOSCIENCES INC. — Investor Relations & Filings

Ticker · DRUG ISIN · CA10919W1086 US Manufacturing
Open in API
Filings indexed 161 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country US United States of America
Listing US DRUG

About BRIGHT MINDS BIOSCIENCES INC.

https://brightmindsbio.com/

Bright Minds Biosciences Inc. is a biotechnology company developing novel treatments for neurological and psychiatric disorders. The company's approach focuses on healing the central nervous system and brain through the regulation of serotonin. Using a proprietary chemistry platform, Bright Minds develops highly selective serotonin receptor agonists, specifically targeting 5-HT2A and 5-HT2C receptors while avoiding 5-HT2B activity to improve the safety profile of its drug candidates. Its therapeutic pipeline addresses conditions such as epilepsy, neuropsychiatric disorders, and pain, with dedicated programs for rare diseases like Prader-Willi Syndrome.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is an SEC Form 6-K (Report of Foreign Private Issuer), which is a miscellaneous regulatory submission under the Exchange Act. It simply files exhibits (AGM notice, proxy materials, etc.) rather than containing the substantive report itself. This falls under the fallback category “Regulatory Filings (RNS).”
2026-06-03 English
FORM 6-K
Regulatory Filings Classification · 90% confidence The document is a U.S. SEC Form 6-K submitted by Bright Minds Biosciences Inc., a short regulatory report of a foreign private issuer attaching Exhibit 99.1 (Notice of Annual General Meeting and Record Date). It does not contain substantive financial data or full report content itself but is an SEC submission. No specific category for Form 6-K exists in the taxonomy, so it falls under the general regulatory filings category.
2026-06-02 English
FORM 6-K
Regulatory Filings Classification · 75% confidence The document is a U.S. SEC Form 6-K filing by a foreign private issuer (Bright Minds Biosciences) furnishing interim consolidated financial statements, MD&A and certifications as exhibits. It does not contain the full interim report data in the body but references exhibits filed herewith. Under our taxonomy, Form 6-K is a regulatory filing that does not squarely fit into the other specific categories, making "Regulatory Filings (RNS)" the appropriate classification.
2026-05-19 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.